FL H0063

Repeals existing s. 381.986 and creates "The Florida Low-THC Cannabis Act" (ss. 381.99-381.9991) establishing a comprehensive regulatory framework for medical low-THC cannabis (no more than 0.8% THC)

Authorizes registered patients with qualifying conditions (cancer, HIV/AIDS, epilepsy, ALS, multiple sclerosis, Crohn's disease, Parkinson's disease, or terminal illness) and their designated caregivers to purchase, possess, and use low-THC cannabis from licensed retail facilities

Establishes three license types administered by the Department of Health: cultivation licenses ($100,000 application fee, $2 million bond), processing licenses ($100,000 application fee, $2 million bond), and retail licenses ($10,000 application fee, $250,000 bond), all expiring after 2 years

Requires physicians to complete an 8-hour course and examination before certifying patients, and mandates independent laboratory testing of all products before distribution with child-resistant packaging and specific labeling requirements

Prohibits use in public places, on school grounds, in correctional facilities, and while driving or boating; counties must approve retail locations by ordinance; retail facilities cannot be within 1,000 feet of schools or childcare facilities